Grifols announced on Thursday that it has signed a strategic agreement with Swiss laboratory automation firm Inpeco to provide automated instrumentation, robotics, and software to transfusion medicine ...

Grifols has signed a strategic agreement with Inpeco to provide transfusion medicine labs with complete, tailored ...

Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J. Fox Foundation for Parkinson’s ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Monday, March 17, 2025. Let’s take a ...

Spanish plasma-derived medicines specialist Grifols (MCE: GRF) has announced positive results from its Phase II/III clinical ...

Recent human trials of a new one-year-long immune-based treatment for post-polio syndrome, which can strike polio survivors ...

Grifols has shared positive results from its clinical trial evaluating the efficacy and safety of intravenous immunoglobulin to treat patients with PPS.

Grifols has announced positive results from its phase 2/3 clinical trial evaluating the efficacy and safety of intravenous ...

Grifols shares lost more than 5% on the stock market on Monday. Last Friday, after the market had closed, a report was ...

Deutsche Bank raised the firm’s price target on Grifols (GRFS) to EUR 11 from EUR 10 and keeps a Hold rating on the shares.Optimize Your ...

Grifols (GRFS) issued a statement to address certain information published in a media outlet on March 8, specifically a front-page article ...

As European markets face uncertainty due to U.S. trade policy and recent ECB rate cuts, the pan-European STOXX Europe 600 Index has snapped a 10-week streak of gains, although increased defense and ...